Advertisement

Topics

Agenix Limited Company Profile

09:53 EST 22nd November 2017 | BioPortfolio

Our VisionAgenix aims to continue to be at the forefront of biotechnology, with a major focus on the development of monoclonal antibodies into innovative medical products.

Corporate Overview
Agenix Limited is a leading edge biotechnology company with operations through its wholly owned subsidiary AGEN Biomedical Limited ("AGEN")

AGEN specialises in advanced medical diagnosis of human diseases and is well positioned as a world-class thrombosis and blood clot specialist. Building on existing technology platforms, AGEN is continuously investing in research and development. AGEN is in the process of commercialising a breakthrough technology in blood clot imaging called ThromboView®.

Location

7 Durbell Street
Acacia Ridge
QLD 4110,
Australia

Contact

Phone: 61 7 3370 6300
Fax: 61 7 3370 6370
Email: info@agen.com.au


News Articles [21 Associated News Articles listed on BioPortfolio]

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering

MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [82 Associated Companies listed on BioPortfolio]

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Agenix Limited

Our VisionAgenix aims to continue to be at the forefront of biotechnology, with a major focus on the development of monoclonal antibodies into innovative medical products. Corporate OverviewAgenix Lim...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Agenix Limited" on BioPortfolio

We have published hundreds of Agenix Limited news stories on BioPortfolio along with dozens of Agenix Limited Clinical Trials and PubMed Articles about Agenix Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Agenix Limited Companies in our database. You can also find out about relevant Agenix Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record